UBS Group’s Cellectar Biosciences, Inc. Series A Warrants CLRBZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,596
| Closed | -$1K | – | 9100 |
|
|
2021
Q1 | $1K | Sell |
1,596
-28,027
| -95% | -$17.6K | ﹤0.01% | 7859 |
|
|
2020
Q4 | $4K | Buy |
29,623
+26,405
| +821% | +$3.57K | ﹤0.01% | 6934 |
|
|
2020
Q3 | $0 | Buy |
3,218
+3,149
| +4,564% | – | ﹤0.01% | 7633 |
|
|
2020
Q2 | $0 | Sell |
69
-1,221
| -95% | – | ﹤0.01% | 7498 |
|
|
2020
Q1 | $0 | Sell |
1,290
-1,204
| -48% | – | ﹤0.01% | 7412 |
|
|
2019
Q4 | $0 | Sell |
2,494
-6
| -0.2% | – | ﹤0.01% | 7331 |
|
|
2019
Q3 | $0 | Buy |
+2,500
| New | – | ﹤0.01% | 7292 |
|
|
2018
Q4 | – | Sell |
-14,674
| Closed | -$1K | – | 7343 |
|
|
2018
Q3 | $1K | Buy |
+14,674
| New | +$1K | ﹤0.01% | 6956 |
|
|
2017
Q3 | – | Sell |
-3,260
| Closed | -$2K | – | 6990 |
|
|
2017
Q2 | $2K | Sell |
3,260
-2,700
| -45% | -$1.66K | ﹤0.01% | 6471 |
|
|
2017
Q1 | $5K | Buy |
5,960
+5,780
| +3,211% | +$4.85K | ﹤0.01% | 6086 |
|
|
2016
Q4 | $0 | Buy |
+180
| New | – | ﹤0.01% | 6987 |
|